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Description

Adipose tissue (AT) has diverse and important functions in body insulation, mechanical
protection, energy metabolism and the endocrine system. Despite its relative abundance in
the human body, the clinical significance of AT in musculoskeletal (MSK) medicine, particularly its role in painful MSK conditions, is under-recognized. Pain associated with AT can
be divided into intrinsic (AT as a primary pain generator), extrinsic (AT as a secondary pain
generator) or mixed origin. Understanding AT as an MSK pain generator, both by mechanism
and its specific role in pain generation by body region, enhances the clinical decision-making
process and guides therapeutic strategies in patients with AT-related MSK disorders. This
article reviews the existing literature of AT in the context of pain generation in the lower
back and lower extremity to increase clinician awareness and stimulate further investigation
into AT in MSK medicine.

MoutainView Medical
Center
2880 N Tenaya Way, 2nd Fl,
Las Vegas, NV 89128
(sewlee2014@gmail.com)

Keywords

adipose tissue; fat pad; musculoskeletal pain; connective tissue; lipodystrophy; lipoma; obesity; lipedema; pain generator

Introduction

Mounting evidence supports the various functions of adipose tissue (AT), most notably its
link to obesity and metabolic dysfunction.1-3
Aside from the impact of obesity on the musculoskeletal (MSK) system, the role of AT in
painful MSK conditions is less established.
Historically, AT masses/lipomas were considered common pain generators. However, the
high prevalance of asymptomatic lipomas,4,5
inconsistent responses to local injections and
increasing awareness of other neighboring pain
generators disputed their reputation in painful
MSK conditions. AT has recently re-entered
the focus of MSK clinicians, most notably for
its use in regenerative medicine.6 Moreover,
localization and evaluation with high resolution
imaging technologies has improved understanding of AT in other contexts, particularly
pain generation. Therefore, our objective is to
review the available literature on AT-related
painful MSK disorders in the lower back and

lower extremity, focusing on its pathogenic role
as a pain generator as well as practical diagnosis and management.

Distribution, Physiologic Changes
and Mechanical Properties of
Adipose Tissue

AT is largely located in subcutaneous regions,
followed by visceral regions. Ectopic areas
of deposition include bone marrow and the
retro-orbital, intramuscular, intermuscular
and periarticular regions.7 With aging, there is
global redistribution of AT from subcutaneous
to truncal/visceral regions.8 Local redistribution
also occurs, as seen in AT on the plantar aspect
of the heel and metatarsophalangeal joints.9 In
addition, aging AT cells undergo cellular senescence, a process that promotes AT dysfunction
through dysregulation of extracellular remodeling, inflammation and pathologic angiogenesis.10

www.hcahealthcarejournal.com
© 2020 HCA Physician Services, Inc. d/b/a
Emerald Medical Education

HCA Healthcare
Journal of Medicine

257

HCA Healthcare Journal of Medicine

AT is a highly expandable connective tissue
comprised of adipocytes (lipid-filled cells)
enclosed within collagen-based structures
(basement membrane and interlobular septa)
and smaller numbers of fibroblasts.11 It protects
the underlying MSK structures, contributes to
mechanical stability and resists shear strain.12
Nonetheless, the mechanical integrity of AT
varies between individuals and over an individual’s lifespan. For example, the stiffness and
thickness of heel AT was found to be higher in
overweight and obese individuals as compared
to normal-weight individuals.12 This discovery is
partly explained by increased fibrosis, a process
that limits the ability of adipocytes to expand.13
Increased stiffness can also reflect a degenerative process, as repetitive microtrauma reduces
water content and elastic fibrous tissues.13-15
Furthermore, septal hypertrophy and fragmented elastic fibers in heel AT occurs with aging.12 These changes can negatively impact the
mechanical properties of AT and consequently
its functions in shock absorption and resistance
to compressive and sheer forces of gait.12

Adipose Tissue as an Intrinsic and
Extrinsic Pain Generator
Pain-related to AT falls into two categories: 1)
Intrinsic: pain originating directly from/within
AT and 2) Extrinsic: pain related to the interaction of AT with surrounding structures. Mixed
processes are not uncommon.

Intrinsic Pain Generation

Dye et al. described pain perception of different intraarticular structures in a conscious individual by arthroscopic probing and found the
infrapatellar fat pad to be both highly localized
and sensitive compared to neighboring structures.16 In an alternative study, similar noxious
responses were induced by injecting hypertonic saline (5%) into the infrapatellar fat pad.17
Such findings underscore the rich nociceptive
innervation of fat pads by substance-P and
calcitonin gene-related peptide nerve fibers
and lend credibility to pain originating directly
from AT.18 Moreover, AT is metabolically active
and produces proinflammatory adipokines
such as tumor necrosis factor-alpha, leptin,
vaspin, chemerin and interleukin-6.3,19,20 As an
example, pain syndromes due to inflamed fat
pads are well described in patients with HIV.
These pain syndromes include retrocalcaneal
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pain from isolated inflammation of Kager’s fat
pad and nonspecific anterior knee pain related
to inflammation of the infrapatellar fat pad.21
AT torsion resulting in inflammation and/or
ischemic necrosis is amongst other proposed
mechanisms of AT-based pain.22

Extrinsic Pain Generation

Painful MSK conditions can be related to the
interaction of AT with surrounding structures,
i.e., extrinsic pain generator. Lipomas, for example, are AT masses that can arise from any
location where fat is normally present. Local
pain in lipomas can result from irritation of a
fascial layer or other neighboring structures,
such as bursa and nerve.23 If nerve irritation occurs, distant pain (either radiating or referred)
can be experienced.24 The pain characteristics
and presentation of painful fat pads/symptomatic lipoma will vary based on the body
region and surrounding structures. (Table 1) As
another example, increased adiposity can cause
tendinopathy due to direct mechanical loading
and biochemical alterations caused by systemic
dysmetabolic factors.25 Rich neovascularization and sensory innervation of AT surrounding
tendons may also play a role in chronic tendon
pain.26 In addition, there is evidence that AT can
contribute to the development of osteoarthritis via adipokines, such as leptin, visfatin and
resistin.19 Other processes, such as the loss of
the AT structural integrity, can contribute to
pain generation. This loss is observed in plantar
fat pad atrophy.27

Mechanisms and Biomechanics of
Musculoskeletal Pain Generation:
Regional Approach
Lower Back and Buttock

Episacroiliac subcutaneous lipomas, or “back
mice,” are subfascial fat herniations that may
be encountered in patients with nonspecific
low back pain.4 These lipomas are often bilateral and located near the sacroiliac “dimple,”
posterior iliac crest and lumbar paraspinal area.
(Figure 1) There appears to be a female predilection. Subfascial herniation to the myofascial
layer makes symptomatic lipoma difficult to
distinguish from myofascial pain syndrome. A
discrete, large and painful palpable nodule favors lipoma herniation rather than a myofascial
trigger point.23
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Table 1. Classification of painful adipose tissue/fat pad disorders affecting lower back and lower
extremity
Location

Common pathologies

Characteristics and suggested mechanisms of pain

Systemic Adipose Tissue Disorders
General

Partial

Lipodystrophy
(congenital and
acquired)

Chronic pain with neuropathic pain most common, followed by arthralgia, muscle pain Common chronic peripheral neuropathy

Lipedema

Pain and tenderness in the bilateral lower extremities,
skin hypersensitivity, neural tissue compression within the
septa surrounding fat lobules

Partial lipodystrophy
(acquired)

Hoffa’s fat pad with anterior (infrapatellar) knee pain and
Kager’s fat pad with posterior heel pain, anterior to the
Achilles tendon in patients with HIV infection

Adiposis dolorosa
(Dercum’s disease)

Painful subcutaneous adipose tissues involving extremities, torso and even face

Adipose Tissue Pain Generation by Body Region
Subcutaneous painful
fat pad

Episacroiliac subcutaneous lipomas, “back mice”, irritating
myofascia, fascial herniation and torsion of fat pad, commonly in the episacral region, often bilateral
Can cause neuropathic pain by irritation of cluneal nerves

Lower back
and buttock
Spinal lipoma

Lipomyelomeningocele (fatty mass in conus medullaris),
lipoma of the terminal filum causing tethered cord/root
syndrome
Spinal epidural lipomatosis (primary and secondary) with
lumbosacral radiculopathy

Hip and
thigh

Knee

Painful fat pad
Lipoma
Painful fat pad
Lipoma arborescens
Lipoma
Painful fat pad

Ankel and
foot

Fat pad atrophy and
migration
Piezogenic pedal
papules

Femoral fat pad entrapment with femoroacetabular
impingement, anterior inferior iliac spine fat pad causing
adhesion of joint capsule and gluteal muscle
Deep large intramuscular lipoma with thigh pain
Hoffa’s infrapatellar fat pad impingement, suprapatellar,
prefemoral fat pad impingement syndrome (hyperextension of knee) with anterior knee pain
Involving suprapatellar recess
Retrocalcaneal bursitis
Insertional Achilles tendinopathy
Nociceptive pain on the heel (plantar aspect) and forefoot
(metatarsalgia)
Subcutaneous fat herniation in the heel, especially in
weight bearing

Lipomas of the spinal cord are rare tumors often associated with occult spinal dysraphism.24
Spinal lipomas are more commonly located in
the conus medullaris and called lipomyelomeningocele. Lipomyelomeningocele is characterized by a subcutaneous fibrofatty mass, lamina
defect, compressive myelopathy and tethered
cord syndrome.28 It can present with progres-

sive neurological deficit in the lower extremities
with the loss of bladder function.24 Lipoma of
the terminal filum is another common cause of
tethered cord syndrome with lower back pain as
the first presenting symptom.29 Spinal epidural
lipomatosis is extremely uncommon and can be
found incidentally or present symptomatically as
radiculopathy, neurogenic claudication and
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Figure 1. Ultrasonographic figure of multiple fat pads on the lumbosacral region in a patient with
chronic low back pain.
myelopathy.30 It has been associated with exogenous steroid use (epidural or chronic systemic
steroids), endogenous hypercortisolism (Cushing’s syndrome), hypothyroidism, hyperprolactinemia and protease inhibitors in patients with
HIV.31 Spinal epidural lipomatosis is most often
localized to the thoracic spine followed by lumbosacral spine.30,32

Hip and Thigh

Femoral fat pads were recently recognized as
a source of pain in femoroacetabular impingement syndrome, with fat pad entrapment
occurring between the femoral head-neck
junction and labrum. In patients with cam-type
femoroacetabular impingement, Jayasekera
et al. observed similar clinical outcomes with
arthroscopic resection of the femoral fat pads
in the anterior head-neck junction with or
without creating a spherical femoral head.33 In
addition, anterior inferior iliac spine fat pads
have been implicated in anterior groin pain as a
consequence of inflammation, fibrosis, scar and
adhesion (between the joint capsule, rectus
femoris and gluteus muscles).34
Most lipomas in the thigh are asymptomatic
but can be painful when situated deep (under
the enclosing fascia, in the intramuscular and
intermuscular layers) or if they are large (usually due to the expansion of soft tissue or compression of the peripheral nerve).35,36
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Knee

Infrapatellar or Hoffa’s fat pad impingement
syndrome is a well-known cause of anterior
knee pain that occurs at either the infrapatellar
or peri-patellar region during knee hyperextension. Hoffa’s fat pad can be impinged by any
combination of neighboring structures, including the patella and patellar tendon anteriorly,
femoral condyle posteriorly and proximal tibia
caudally.37 (Figure 2) A minor injury to Hoffa’s
fat pad, including hyperextension with or without twisting and a direct trauma, can cause
swelling, inflammation, fibrosis and scarring
that contributes to the altered biomechanics
and increased pain perception.37 Anterior knee
pain can also result from anterior suprapatellar
fat pad impingement. This triangular-shaped
fat pad is located on the superior edge of the
patella (underneath the quadriceps tendon,
anterior/superficial to the suprapatellar recess).38,39 Impingement occurs during maximal
knee flexion. Lastly, the prefemoral fat pad, located proximal to the femoral trochlea, can be
impinged between the patella and anterolateral
surface of the distal femur during flexion and
extension of the knee.40,41
Lipoma arborescens is a benign, “tree-like”
AT lesion characterized by the replacement
of subsynovial connective tissue with AT and
synovial villous proliferation. This replacement
can result in intermittent painful swelling of
the knee joint, typically involving the suprapa-
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tellar bursa.42 Other reported locations include
the hip and ankle joints. It is more common
in males between the 5th and 6th decades of
life and is associated with osteoarthritis and
inflammatory arthropathy.43

Ankle and Foot

Kager’s fat pad is bordered by the Achilles
tendon, retrocalcaneal bursa and flexor hallucis
longus tendon in the posterior ankle.44 (Figure
2) It reduces tendon kinking and minimizes
pressure on the bursa.45 Patients with Kager’s
fat pad impingement can present with a painful
bulging mass at the retrocalcaneal space of the
posterior ankle. Symptoms are exacerbated by
ankle plantarflexion with a knee hyperextension
(recurvatum) momentum in a closed kinetic
chain movement. Pathologies of the neighboring structures and lipodystrophy (LD) of the
fat pad can also contribute to impingement.21

A lipoma beneath the flexor retinaculum of the
tarsal tunnel can cause tarsal tunnel syndrome.
It manifests with pain behind the medial malleolus that radiates to the plantar aspect of the
foot.46,47
Fat pad atrophy and migration occurs in the
sole of an aging foot at the superficial to medial calcaneal tuberosity48 and under the metatarsal heads. It is often associated with plantar
heel pain, metatarsalgia and metatarsal subluxation. In addition to normal age-related changes, fat pad atrophy can occur as a consequence
of steroid injections.49,50
Piezogenic pedal papules are herniations of the
subcutaneous fat into the plantar fascia retinaculum. They are common incidental findings
in weight-bearing areas of the foot, particularly
the plantar heel fat pad.51 The papules may only
be visible in full weight-bearing. Although a

Figure 2. Ultrasonographic figures of fat pads (yellow colored line) in the anterior knee (right
upper corner) and the posterior ankle (left lower corner). Red arrows indicate proposed impingement mechanisms of these fat pads.
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majority of lesions are asymptomatic, papules
may be discretely tender on palpation. Irritation
of local nerves and blood vessels by repetitive
trauma can contribute to pain.52

Systemic Adipose Disorders

Although painful MSK conditions related to focal AT are the main focus of this paper, systemic adipose disorders, in particular lipedema and
lipodystrophy (LD), may likewise cause lower
back and lower extremity pain and, therefore,
will be briefly reviewed.
LD is a heterogeneous group of disorders
characterized by abnormal distribution of AT,
including AT loss or hypertrophy.53,54 LD can be
classified into primary (idiopathic or familial)
versus secondary depending on the underlying etiology (HIV, panniculitis, autoimmune,
medication, trauma), or general versus partial
depending on the extent of involvement.55-57
More than 70% of patients with LD suffer
from chronic pain, most commonly neuropathic pain, followed by arthralgia and muscle
pain amongst others. Peripheral sensory-motor neuropathy is found in more than 60% of
patients with LD and diabetes.58 Underlying
mechanisms for peripheral neuropathy in LD
are not entirely clear but likely include a combination of metabolic dysfunction and a failure
of the shock-absorbing function of peripheral
nerves. Specifically, loss of epineural fat components is thought to contribute to chronic
trauma, inflammation/pressure palsies and
denervation.58-61 Muscle pain is common in
congenital LD, but readily apparent myopathy
is not common in LD other than a late complication of juvenile dermatomyositis.58
Lipedema, a type of LD, is characterized by
abnormal deposition of subcutaneous AT,
frequently involving the lower extremities
symmetrically.62-64 There is a demographic
predilection for females of a younger age and
commonly a family history.62 A typical patient
complaint is pressure,-mediated leg pain and
tenderness. These symptoms may be a consequence of neural compression within the septa
surrounding fat lobules. Other potential mechanisms include hypersensitivity, mechanical
friction and skin irritation.62 As the hypertrophy
extends from hips to ankles, lipedema may
be misdiagnosed as lymphedema.62 In comparison, lymphedema is typically painless and
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involves the foot, whereas lipedema commonly
spares the foot with a step-off (cuff sign) at
the ankle.65 The absence of pain and edema can
differentiate lipohypertrophy from lipedema.64
Adiposis dolorosa, also known as Dercum’s
disease, shares similar clinical features with
lipedema, such as painful subcutaneous AT and
a predominance in females between the ages
of 35–50 years.66,67 Fat involvement of the torso
in early stages of the disease, greater pain
severity and comorbidities such as fibromyalgia
and metabolic disease distinguishes adiposis
dolorosa from lipedema.68,69

Evaluation with Imaging
Modalities

A majority of MSK disorders related to AT are
clinically diagnosed. Imaging modalities are
helpful to confirm the clinical diagnosis, evaluate differential diagnoses and aid in the identification of indiscrete masses in patients with
larger body habitus. With the increasing availability of ultrasonography (US) in outpatient
clinics, lipomas can be easily visualized in-office
(Figure 1). Typical findings include a partially
or well-encapsulated mobile mass with similar
echogenicity to the neighboring fat (hypoechoic or isoechoic depending on the heterogenicity
of AT and water components) and absence of
acoustic shadowing.70,71 Differential diagnoses
for subcutaneous AT masses include epidermal
cyst, ganglion cyst and malignant neoplasm.
Epidermal cysts are isoechogenic, which is
similar to subcutaneous lipomas. However,
post-acoustic enhancement and lateral shadowing are differentiating characteristics. Ganglion cysts typically demonstrate anechogenicity within the cyst, with protrusion towards a
neighboring joint.72 US imaging of soft tissue
malignant neoplasms, most commonly pleomorphic sarcoma and liposarcoma, can mimic
a lipoma. However, they typically demonstrate
larger size (≥ 5 cm), are intramuscular, have an
infiltrative border, grow rapidly and violate tissue planes.71 Differential diagnoses for deep-lying lipomas in US evaluation are extensive and
vary depending on mass location. These differential diagnoses may include congenital cysts,
ganglion cyst, heterotopic ossification, hemangiomas, angiolipoma, hematoma, lymph nodes,
normal muscle/muscle herniation and malignant tumors, amongst others.36,73 Sonoelastography provides information on intrinsic tissue
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properties. This information aides in the delineation of malignant tumors, which are generally
stiffer than benign masses.74,75 Any suspicion for
malignant neoplasm requires further imaging
studies and the definite diagnosis with histopathologic and molecular examination.
MRI is useful when US assessment is difficult. Examples include deeper, intraarticular
or intracortical lesions.76 On both T1 and T2
weighted images, lipomas demonstrate high
signal intensity, while fat-suppression sequences show decreased signal intensity.36 Increased
lipoma signal intensity on fat-suppression
sequences may indicate edema/fluid, necrosis
or mass heterogeneity (as seen in an atypical
tumor or liposarcoma).77 An MRI can also evaluate neighboring structures such as ganglion
cyst, plica, synovium, ligament, meniscus, bony/
tendon edema or any neoplastic lesions.37 A CT
can similarly be utilized to evaluate lipomas,
which would appear as a hypodense mass with
attenuation similar to fat tissue. A CT can be
particularly useful to delineate subtle ossification/calcification and associated cortical bony
lesions.78 An x-ray is limited in the evaluation
of soft tissue lesions (lipoma) in general but
serves utility in the identification of intraosseous lipomas mimicking other diseases such as
fibrous dysplasia, aneurysmal bone cysts, simple cysts, bone infarcts and chondral tumors.79

through the plantar fat (during plantar fascia
and intermetatarsal bursa/neuroma injections) should be avoided to prevent atrophy.
Ethanol-based nerve fiber ablation has been
previously attempted to mitigate pain associated with AT. However, caution is required as
AT scarring and denaturing can occur. Biomechanical evaluation and avoiding faulty training
(with repetitive trauma) should be considered
a means to alleviate pain and prevent progression and recurrence. Symptomatic Hoffa’s fat
pad impingement with pes cavus may respond
to heel lift placement by mitigating knee extension moments known to aggravate symptoms.82 Placing a pillow under the knee avoids
full knee extension, relieving pain associated
with sleeping in the supine position.

The first step for the successful management
of symptomatic AT is to recognize AT as a
pain generator and investigate the underlying
mechanisms for the pain. This review primarily
focuses on the management of focal AT-related
painful MSK disorders; LD will be briefly covered.

Weight loss should also be emphasized to
decrease metabolic dysfunction and the biomechanical disadvantages associated with
increased weight. Weight loss has favorable
impacts on pain and biomechanics of the lower
extremity, including decreased foot plantar
loading pressure, increased ankle plantarflexion, knee joint motion (maximal knee flexion),
compressive force and peak moments around
the hip and knee.83-85 However, evidence reflecting the impact of weight loss in AT-related
painful MSK disorders is scarce and unclear.
Okifuji and Hare suggested obesity may not
impact pain response in the absence of inflammation or nerve injury, though obesity can
potentiate inflammatory response.86 Dodet et
al.87 and Zahorska-Markiewicz et al.88 reported
higher pain thresholds among the obese population compared to the nonobese population.
Although the exact mechanisms were not clear,
ghrelin and galanin were suggested for modulation of the obesity-induced change in pain
threshold.89,90 Regardless of the direct impact
of obesity and weight loss on AT-related pain,
aerobic endurance exercise is important to
decrease complications related to chronic MSK
pain and to improve metabolic dysfunction.91

Local, non-pharmacological interventions that
may improve AT-related disorders in the lower
back and lower extremities include orthotics,
taping and modification of daily activity. For
fat pad atrophy and migration in the foot, heel
cups (rubber or felt pad) and low dye taping
can be tried for heel pain and a metatarsal pad
for metatarsalgia.81 Repeat steroid injections

Surgical options can be considered in patients
who fail conservative treatment and have disabling pain. Potential interventions include fat
pad resection in impingement syndrome. These
interventions include intraarticular or extraarticular fat pad resection in anterior groin pain,
Hoffa’s fat pad resection in anterior knee pain
and Kager’s fat pad resection in retrocalcaneal

Clinicians should be aware of the limitation
of imaging modalities, including inconsistent
relationships between the imaging findings and
the local pain.80

Management
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heel pain.34,92,93 Scarring of the surgical site and
the impact of regional stability can be challenging postoperatively. Alternatively, US guided
scraping of vascularized fat pads can relieve
pain from neighboring chronic tendinopathy.26
A few studies highlight the non-cosmetic implantation of fat for fat pad atrophy, such as
fat grafting for metatarsalgia and chronic heel
pain.27,94,95
As it pertains to LD, management should focus
on symptomatic manifestations and metabolic
syndrome. Recombinant human leptin (metreleptin) is considered for generalized LD, with
low serum leptin levels to improve metabolic
syndrome and weight loss.96,97 In secondary LD,
recognizing and managing the underlying etiology is useful for successful treatment.98

Conclusion

AT should be recognized as one of the pain
generators in painful musculoskeletal disorders.
Therapeutic strategies for adipose tissue-related pain disorders could be better guided by
understanding the mechanism by which AT-related pain is occurring.
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